CT
Therapeutic Areas
Cerevance Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Solengepras (CVN424) | Parkinson's Disease (Adjunctive Therapy) | Phase 3 |
| CVN293 | Neurodegenerative Diseases (e.g., FTD, ALS, Alzheimer's) | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| Solengepras (CVN424) | Parkinson's Disease (Adjunctive Therapy) | Phase 3 |
| CVN293 | Neurodegenerative Diseases (e.g., FTD, ALS, Alzheimer's) | Phase 1 |